{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:29:02Z","timestamp":1790983742076,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T00:00:00Z","timestamp":1399593600000},"content-version":"vor","delay-in-days":1742,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1593\/neo.09506","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T09:08:39Z","timestamp":1429780119000},"page":"793-803","source":"Crossref","is-referenced-by-count":44,"title":["Neutrophil Influx and Chemokine Production during the Early Phases of the Antitumor Response to the Vascular Disrupting Agent DMXAA (ASA404)"],"prefix":"10.1016","volume":"11","author":[{"given":"Liang-Chuan S.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu B.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofian M.","family":"Tijono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Jen J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine E.","family":"Angel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Rod","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai-Ming","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/neo.09506_bib1","first-page":"217","article-title":"Potential antitumor agents","volume":"34","author":"Rewcastle","year":"1991","journal-title":"61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids. JMed Chem"},{"key":"10.1593\/neo.09506_bib2","first-page":"631","article-title":"Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice","volume":"70","author":"Plowman","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"10.1593\/neo.09506_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0277-5379(89)90018-7","article-title":"Comparison of the effects of flavone acetic acid, fostriecin, homohar- ringtonine and tumour necrosis factor alpha on colon 38 tumours in mice","volume":"25","author":"Baguley","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1593\/neo.09506_bib4","first-page":"3304","article-title":"Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice","volume":"59","author":"Ching","year":"1999","journal-title":"Cancer Res"},{"key":"10.1593\/neo.09506_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/sj.bjc.6690415","article-title":"Thalidomide increases both intra-tumoural tumour necrosis factor-a production and anti-tumour activity in response to 5,6-dimethylxanthenone-4- acetic acid","volume":"80","author":"Can","year":"1999","journal-title":"Br j Cancer"},{"key":"10.1593\/neo.09506_bib6","first-page":"633","article-title":"Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy","volume":"59","author":"Joseph","year":"1999","journal-title":"Cancer Res"},{"key":"10.1593\/neo.09506_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.bjc.6600479","article-title":"The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knock- out mice","volume":"87","author":"Zhao","year":"2002","journal-title":"Br j Cancer"},{"key":"10.1593\/neo.09506_bib8","first-page":"4684","article-title":"Activation of LPS- inducible genes by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid in primary routine macrophages","volume":"153","author":"Perera","year":"1994","journal-title":"Dissection of signaling pathways leading to gene induction and tyrosine phosphorylation. J Immunol"},{"key":"10.1593\/neo.09506_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3727\/000000006783981288","article-title":"Inhibition of DMXAA-induced tumor necrosis factor production in routine splenocyte cul- tures by NF-kappaB inhibitors","volume":"16","author":"Wang","year":"2006","journal-title":"Oncol Res"},{"key":"10.1593\/neo.09506_bib10","first-page":"1517","article-title":"Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6- dimethylxanthenone-4-acetic acid (DMXAA)","volume":"61","author":"Can","year":"2001","journal-title":"Cancer Res"},{"key":"10.1593\/neo.09506_bib11","doi-asserted-by":"crossref","first-page":"11752","DOI":"10.1158\/0008-5472.CAN-05-1658","article-title":"Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8' T -cell-mediated antitumor immune response in routine models of lung cancer and mesothelloma","volume":"65","author":"Jassar","year":"2005","journal-title":"Cancer Res"},{"key":"10.1593\/neo.09506_bib12","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1158\/0008-5472.CAN-06-3757","article-title":"The vascular disrupting agent, DMXAA, directly acti- vates dendritic cells through a MyD88-independent mechanism and generates antitumor cytotoxic T lymphocytes","volume":"67","author":"Wallace","year":"2007","journal-title":"Cancer Res"},{"key":"10.1593\/neo.09506_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2008.02.005","article-title":"Three-colour fluorescence immunohistochemistry reveals the diversity of cells staining for mac- rophage markers in routine spleen and liver","volume":"334","author":"Lloyd","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1593\/neo.09506_bib14","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1182\/blood-2008-06-165266","article-title":"Distinctive localization of antigen presenting cells in human lymph nodes","volume":"113","author":"Angel","year":"2009","journal-title":"Blood"},{"key":"10.1593\/neo.09506_bib15","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.176.10.5730","article-title":"Cutting edge: CDla+ antigen-presenting cells in human dermis respond rapidly to CCR7 ligands","volume":"176","author":"Angel","year":"2006","journal-title":"J Immunol"},{"key":"10.1593\/neo.09506_bib16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bcp.2003.10.023","article-title":"Induction of tumour necrosis factor and interferon-gamma in cultured routine splenocytes by the antivascular agent DMXAA and its metabolites","volume":"67","author":"Wang","year":"2004","journal-title":"Bio- chem Pharmacol"},{"key":"10.1593\/neo.09506_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<343::AID-PATH522>3.0.CO;2-M","article-title":"Regulation of inflammatory vascular damage","volume":"190","author":"Lentsch","year":"2000","journal-title":"J Pathol"},{"key":"10.1593\/neo.09506_bib18","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/sj.bjc.6600368","article-title":"Induction of endothelial cell apoptosis by the antivascular agent 5,6-dimethylxanthenone- 4-acetic acid","volume":"86","author":"Ching","year":"2002","journal-title":"Br j Cancer"},{"key":"10.1593\/neo.09506_bib19","first-page":"79","article-title":"Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents","volume":"6","author":"Zwi","year":"1994","journal-title":"Oncol Res"},{"key":"10.1593\/neo.09506_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/bjc.1998.512","article-title":"Enhancement ofthe anti-tumour effects ofthe antivascular agent 5,6dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs","volume":"78","author":"Lash","year":"1998","journal-title":"Br j Cancer"},{"key":"10.1593\/neo.09506_bib21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1054\/bjoc.2000.1361","article-title":"Determinants of anti-vascular action by combretastatin A-4 phosphate: role of nitric oxide","volume":"83","author":"Parkins","year":"2000","journal-title":"Br j Cancer"},{"key":"10.1593\/neo.09506_bib22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00280-006-0321-7","article-title":"Antitumour action of 5,6-dimethylxanthenone-4-acetic acid in rats bearing chemically induced primary mammary tumours","volume":"59","author":"Lui","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1593\/neo.09506_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0952-7915(94)90006-X","article-title":"Chemokines, leucocyte trafficking, and inflammation","volume":"6","author":"Schall","year":"1994","journal-title":"Current Opinion Immunol"},{"key":"10.1593\/neo.09506_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1081\/IPH-200067702","article-title":"Chimerical anti-TNF-alpha, infliximab, inhibits neutrophil chemotaxis and production of reactive oxygen species by blocking the priming effect of mononuclear cells on neutrophils","volume":"27","author":"Pay","year":"2005","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1593\/neo.09506_bib25","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0959-8049(98)00050-1","article-title":"Antitumor activity of the novel immune modulator 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice lacking the interferon-gamma receptor","volume":"34","author":"Pang","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1593\/neo.09506_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/jir.2007.0992","article-title":"IFN-(3-dependent inhibition of tumor growth by the vascular disrupting agent 5,6-dimethyxanthenone-4-acetic acid (DMXAA)","volume":"28","author":"Roberts","year":"2008","journal-title":"J Inteferon Cytokine Res"},{"key":"10.1593\/neo.09506_bib27","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1084\/jem.20061845","article-title":"The chemotherapeutic agent DMXAA potently and specifically activates the TBKl-IRF-3 signaling axis","volume":"204","author":"Roberts","year":"2007","journal-title":"J Exp Med"},{"key":"10.1593\/neo.09506_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccr.2005.04.014","article-title":"De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent","volume":"7","author":"de Visser","year":"2005","journal-title":"Cancer Cell"},{"issue":"Suppl76","key":"10.1593\/neo.09506_bib29","article-title":"Utilization of known TLR signaling pathways in the activation of routine macrophages by the inflammatory anti-tumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)","volume":"32","author":"Roberts","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1593\/neo.09506_bib30","first-page":"141","article-title":"The effect of 5,6-dimethylxanthenone-4-acetic acid on tumour necrosis factor production by human immune cells","volume":"17","author":"Patel","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1593\/neo.09506_bib31","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/bjc.1997.601","article-title":"Production of tumour necrosis factor-a by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488)","volume":"76","author":"Philpott","year":"1997","journal-title":"Br j Cancer"},{"key":"10.1593\/neo.09506_bib32","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1158\/1078-0432.CCR-05-1939","article-title":"5,6-Dimethylxanthenone-4-acetic acid in the treatment of refractory tumors: a phase I safety study of a vascular disrupting agent","volume":"12","author":"McKeage","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.09506_bib33","article-title":"Phase I pharmacokinetic and pharmacodynamic study of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent","volume":"19","author":"Jameson","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1593\/neo.09506_bib34","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/sj.bjc.6600885","article-title":"5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study","volume":"88","author":"Rustin","year":"2003","journal-title":"Br j Cancer"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558609801358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558609801358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T20:56:17Z","timestamp":1566593777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558609801358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S1476558609801358"],"URL":"https:\/\/doi.org\/10.1593\/neo.09506","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}